Naïve B-cell receptor specific for poliovirus D-antigen (PV-D-BCR)

Naïve B-cell receptors specific for poliovirus D-antigen are membrane-bound immunoglobulins found on the surface of B-lymphocytes that have not yet encountered the poliovirus. These receptors are characterized by their ability to recognize and bind to the native, conformational D-antigen epitopes present on the capsid proteins of poliovirus types 1, 2, and 3 (PubMed: 624434). The D-antigen represents the properly folded, infectious state of the virus, which is the primary target for neutralizing antibodies (WHO: Polio Vaccines). Upon binding of vaccine-derived antigens, such as those in the Inactivated Poliovirus Vaccine (IPV) or Oral Poliovirus Vaccine (OPV), these BCRs initiate intracellular signaling pathways that drive the maturation of the B-cell into memory cells and plasma cells (Janeway's Immunobiology). This process is critical for establishing long-term immunity and preventing poliomyelitis, a debilitating disease caused by poliovirus infection of the central nervous system (CDC: Polio Disease). Understanding the interaction between these receptors and viral epitopes is essential for the design of next-generation polio vaccines and the maintenance of global eradication efforts (Nature: Polio Eradication). These receptors are the primary mediators of the humoral immune response required to neutralize the virus before it can enter the central nervous system. Therapeutic strategies focusing on these receptors involve the administration of antigens that mimic the D-antigen conformation to ensure the production of high-affinity antibodies.

Other names

Poliovirus-specific B-cell receptorD-antigen-specific BCRAnti-poliovirus B-cell receptorConformational D-antigen epitope-specific BCR

Vaccines containing D-antigen epitopes bind to these receptors on naïve B-cells, inducing signal transduction that leads to B-cell proliferation, affinity maturation, and differentiation into neutralizing antibody-secreting plasma cells and memory B-cells.